Boeing Commercial Airplane Company in Seattle inspected by FDA on July 10, 2024

Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda)
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) - Official website
0Comments

On July 10, 2024, the Food and Drug Administration (FDA) carried out an inspection at Boeing Commercial Airplane Company in Seattle, concentrating on food and cosmetics technical assistance, according to data posted on the FDA’s website.

The final FDA report concluded that Boeing Commercial Airplane Company was not required to implement any corrective measures regarding its management operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Benjamin D. Moncarz Chief Financial Officer - FDA

FDA conducted April 15 inspection of Bloodworks Seattle facility

FDA records show a blood and blood products inspection took place at Bloodworks in Seattle on April 15.

Todd M. Lyons, Acting Director, U.S. Immigration And Customs Enforcement

Drug dealer sentenced to five years after Homeland Security investigation in Seattle

A Honduran man has been sentenced to over five years following a major drug trafficking investigation led by Homeland Security Investigations Seattle. Authorities say he played a key role connecting buyers with suppliers distributing fentanyl pills and methamphetamine throughout the Pacific Northwest.

Dr. Mehmet Oz CMS Administrator

Seattle Medicaid spending on alcohol and drug abuse treatment rises to $16,464,492 in 2024

Seattle saw Medicaid expenditures for Alcohol and Drug Abuse Treatment services climb by 20.6% in 2024, indicating shifts in service utilization and payment trends.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Seattle City Wire.